Research graph
References from MIDPHASE HYPERFLUORESCENT PLAQUES AS A BIOMARKER OF DISEASE ACTIVITY IN CENTRAL SEROUS CHORIORETINOPATHY. Local targets link to admitted publications; unresolved targets remain external evidence.
Central serous chorioretinopathy: a personal perspective
10.1016/j.ajo.2009.11.017 · 2010 · External reference
Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options
10.1038/s41433-019-0381-7 · 2019 · External reference
Pachychoroid disease
2019 · External reference
Central serous chorioretinopathy: recent findings and new physiopathology hypothesis
10.1016/j.preteyeres.2015.05.003 · 2015 · External reference
Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders
10.1016/j.preteyeres.2021.100973 · 2022 · External reference
Mid-phase hyperfluorescent plaques seen on indocyanine green angiography in patients with central serous chorioretinopathy
10.3390/jcm10194525 · 2021 · External reference
Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy
10.1097/00006982-199919060-00005 · 1999 · External reference
Association between choroidal vascular hyperpermeability and vortex vein anastomoses in central serous chorioretinopathy
10.1016/j.xops.2025.100901 · 2026 · External reference
Clinical characteristics and multimodal imaging findings of central serous chorioretinopathy in women versus men
10.3390/jcm11061706 · 2022 · External reference
Ten-year follow-up and sequential evaluation of multifocal retinal pigment epithelium abnormalities in central serous chorioretinopathy
10.1007/s00417-023-05985-7 · 2023 · External reference
Clinical characteristics and progression of pachychoroid macular atrophy in central serous chorioretinopathy
10.1016/j.oret.2025.04.005 · 2025 · External reference
One year outcome and predictors of treatment outcome in central serous chorioretinopathy: multimodal imaging based analysis
10.1177/11206721211055018 · 2022 · External reference
Imaging characteristics of bilateral CSCR cases: 12 months follow up
10.1038/s41433-021-01885-4 · 2023 · External reference
Photodynamic therapy for chronic central serous chorioretinopathy
10.1097/00006982-200312000-00002 · 2003 · External reference
Settings and clinical applications of subthreshold micropulse laser therapy: a review
10.3390/jcm13195729 · 2024 · External reference
Real-world practice patterns of eplerenone use for central serous chorioretinopathy
10.1186/s40942-023-00500-w · 2023 · External reference
